Tripos Discovery Research Centre Announces Partnerships With Industry-Leading Pharmaceutical And Life Science Companies

2006-01-25
合作
ST. LOUIS & BUDE, England--(BUSINESS WIRE)--Jan. 25, 2006-- New Deals With CeNeS, Gemin X Biotechnologies, Genzyme, GlaxoSmithKline Research and Development, and Schering-Plough Research Institute Underscore Tripos' Commitment to Chemistry Services Business Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery chemistry and informatics products and services, today announced new collaborations with several prominent pharmaceutical and life science organizations across Europe and North America to provide knowledge-driven customized chemistry services. These agreements encompass a combination of new partnerships and extensions with CeNeS Ltd., Gemin X Biotechnologies Inc., Genzyme Corp., GlaxoSmithKline Research and Development Ltd., and Schering-Plough Research Institute. Terms of the agreements, which were all finalized in the fourth quarter of 2005, were not disclosed.
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。